Pharmaceutical Preparations · DE · CIK 1636282
Pioneering long-acting antibodies for inflammatory and rheumatic diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 3, 2026: 2 sold $1.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 3, 2026 | Burrows Scott LChief Financial Officer | Sell | 2,300 | $40.56 | $93K |
| Mar 3, 2026 | Burrows Scott LChief Financial Officer | Sell | 200 | $41.66 | $8K |
| Mar 2, 2026 | Turtle CameronChief Executive Officer | Sell | 9,100 | $42.49 | $387K |
| Mar 2, 2026 | Turtle CameronChief Executive Officer | Sell | 5,900 | $41.73 | $246K |
| Feb 2, 2026 | Turtle CameronChief Executive Officer | Sell | 14,043 | $32.87 | $462K |
| Feb 2, 2026 | Turtle CameronChief Executive Officer | Sell | 957 | $31.82 | $30K |
| Jan 2, 2026 | Turtle CameronChief Executive Officer | Sell | 12,709 | $30.47 | $387K |
| Jan 2, 2026 | Turtle CameronChief Executive Officer | Sell | 2,191 | $31.79 | $70K |
| Jan 2, 2026 | Turtle CameronChief Executive Officer | Sell | 100 | $32.39 | $3K |
| Dec 1, 2025 | Turtle CameronChief Executive Officer | Sell | 10,995 | $28.73 | $316K |
| Dec 1, 2025 | Turtle CameronChief Executive Officer | Sell | 4,005 | $29.83 | $119K |
| Nov 3, 2025 | Turtle CameronChief Executive Officer | Sell | 28,155 | $23.13 | $651K |
| Nov 3, 2025 | Turtle CameronChief Executive Officer | Sell | 16,845 | $23.66 | $399K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.